Short CommunicationDonepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia
Section snippets
Conflict of interest
The authors declare no conflicts of interest.
Acknowledgement
The authors would like to thank Thecla van Wageningen for her technical assistance.
References (25)
- et al.
Effects of the cognition impairer MK-801 on learning and memory in mice and rats
Behav Brain Res
(2011) - et al.
Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically
Prog Neuropsychopharmacol Biol Psychiatry
(2014) - et al.
Increased expression of the vesicular glutamate transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801
Neuropharmacology
(2012) - et al.
SAR and biological evaluation of SEN12333/WAY-317538: novel alpha7 nicotinic acetylcholine receptor agonist
Bioorg Med Chem
(2009) - et al.
Characteristics of object location memory in mice: behavioral and pharmacological studies
Physiol Behav
(2007) - et al.
Object recognition testing: statistical considerations
Behav Brain Res
(2012) - et al.
Object recognition testing: methodological considerations on exploration and discrimination measures
Behav Brain Res
(2012) - et al.
Subchronic MK-801 treatment and post-weaning social isolation in rats: differential effects on locomotor activity and hippocampal long-term potentiation
Behav Brain Res
(2010) - et al.
Subchronic MK-801 behavioural deficits in rats: partial reversal by the novel nitrate GT 1061
Pharmacol Biochem Behav
(2009) - et al.
NMDA receptors, cognition and schizophrenia – testing the validity of the NMDA receptor hypofunction hypothesis
Neuropharmacology
(2012)
Twenty-five years of glutamate in schizophrenia: are we there yet?
Schizophr Bull
(2012)
Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia
Int J Neuropsychopharmacol
(2013)
Cited by (0)
- 1
Both authors contributed equally to this work.
Copyright © 2014 Elsevier B.V. All rights reserved.